The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 25, 2018
Filed:
May. 17, 2017
Applicant:
Intarcia Therapeutics, Inc., Boston, MA (US);
Inventor:
Karling Alice Leung, Oakland, CA (US);
Assignee:
Intarcia Therapeutics, Inc., Boston, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); C07K 14/605 (2006.01); A61M 31/00 (2006.01); A61K 45/06 (2006.01); A61M 37/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 45/06 (2013.01); A61M 31/002 (2013.01); C07K 14/605 (2013.01); A61M 37/00 (2013.01);
Abstract
The use of GLP-1 receptor agonists, such as glucagon-like peptide-1 (GLP-1) or exenatide, for the treatment of cancer is described. The GLP-1 receptor agonists are typically delivered using an implanted osmotic delivery device that provides for continuous delivery of the GLP-1 receptor agonist for at least one month. Additional beneficial agents, such as anticancer agents, can also be administered.